Opioids and their Receptors

Authors

  • Shreeya Menon Nashua High School South

DOI:

https://doi.org/10.47611/jsrhs.v13i4.7646

Keywords:

Opioids, Mesolimbic dopaminergic system, Endogenous opioid system, opioid receptors, G-protein coupled receptors, opioid-use disorder

Abstract

Opioids, derived from Papaver somniferum, have played a significant role in human history since 3400 BC, spanning recreational and medicinal uses. Opioid receptors in the central and peripheral nervous systems mediate their effects, primarily through inhibitory GABAergic interneurons. These are G-protein coupled receptors, with three primary types: μ, κ, and δ, each influencing various physiological and psychological functions. Opioids are classified based on their action on these receptors as full agonists, partial agonists, mixed agonist-antagonists, or antagonists. The endogenous opioid system, comprising opioid receptors and their endogenous ligands, regulates numerous physiological processes, including nociception, emotional behaviour, learning, memory, and reward pathways.

Addiction to opioids, driven by the mesolimbic dopaminergic system, results in significant neurological changes, leading to tolerance, dependency, and severe withdrawal symptoms. Opioid use can cause short-term effects like analgesia and stress reduction, but long-term use leads to tolerance, dependency, and various physiological disorders. The opioid epidemic in the United States shows the urgent need for a deeper understanding of opioid mechanisms to develop effective treatment and prevention strategies, to address this ongoing crisis with comprehensive knowledge and intervention.

Downloads

Download data is not yet available.

References or Bibliography

Alcaro, A., Huber, R., & Panksepp, J. (2007). Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective. Brain Research Reviews, 56(2), 283–321. https://doi.org/10.1016/j.brainresrev.2007.07.014

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.

Baik, J.-H. (2020). Stress and the Dopaminergic Reward System. Experimental & Molecular Medicine, 52(12), 1879–1890. https://doi.org/10.1038/s12276-020-00532-4

Bear, M., Connors, B., & Paradiso, M. A. (2020). Neuroscience : Exploring the brain, enhanced edition : exploring the brain, enhanced edition. Jones & Bartlett Learning, LLC.

Congressional Research Service. (2022, November 30). The Opioid Crisis in the United States: A Brief History. Congressional Research Service. https://crsreports.congress.gov/product/pdf/IF/IF12260

DEA Office of Diversion Control. (2014). TRAMADOL (Trade Names: Ultram®, Ultracet®). https://www.deadiversion.usdoj.gov/drug_chem_info/tramadol.pdf

Dhaliwal, A., & Gupta, M. (2020). Physiology, Opioid Receptor. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK546642/#:~:text=Opioid%20Receptors%20are%20G%20protein

Drewes, A. M., Jensen, R. D., Nielsen, L. M., Droney, J., Christrup, L. L., Arendt-Nielsen, L., Riley, J., & Dahan, A. (2012). Differences between opioids: pharmacological, experimental, clinical and economical perspectives. British Journal of Clinical Pharmacology, 75(1), 60–78. https://doi.org/10.1111/j.1365-2125.2012.04317.x

Drug Enforcement Administration. (2021). Opium Poppy. Museum.dea.gov. https://museum.dea.gov/exhibits/online-exhibits/cannabis-coca-and-poppy-natures-addictive-plants/opium-poppy

Dumas, E. O., & Pollack, G. M. (2008). Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective. The AAPS Journal, 10(4). https://doi.org/10.1208/s12248-008-9056-1

Navadiya, V. (2021). G Protein Coupled Receptors (GPCR) & G Proteins. In YouTube. https://www.youtube.com/watch?v=5zVysV32hVQ

Opioids. (2012). PubMed; National Institute of Diabetes and Digestive and Kidney Diseases. https://pubmed.ncbi.nlm.nih.gov/31643200/

Restak, R. (2000). Mysteries of the mind. National Geographic Society.

studymedical. (2021, June 8). Opioid agonists, mixed agonist antagonists and partial agonist (Pharmacology). YouTube. https://www.youtube.com/watch?v=z0BybzuhjQQ&t=50s

Tengler, D., L., Hahn, J., & Cataldo, L., Jean. (2020). Opioid-Related disorders. In J. L. Longe (Ed.), Gale Encyclopedia of Medicine (6th ed.). Gale. https://credosource.infobase.com/articles/Qm9va0FydGljbGU6NjQ1NzE=?aid=154696

Trescot, A., Datta, S., Lee, M., & Hansen, H. (2008). Opioid Pharmacology. https://www.painphysicianjournal.com/current/pdf?article=OTg3&journal=42

Trigo, J. M., Martin-García, E., Berrendero, F., Robledo, P., & Maldonado, R. (2010). The endogenous opioid system: A common substrate in drug addiction. Drug and Alcohol Dependence, 108(3), 183–194. https://doi.org/10.1016/j.drugalcdep.2009.10.011

United States Drug Enforcement Administration . (2018). Drug Scheduling. Www.dea.gov; United States Drug Enforcement Administration. https://www.dea.gov/drug-information/drug-scheduling

Urman, R., Elbaridi, N., Kaye, A. D., & Choi, S. (2017). Current Concepts of Phenylpiperidine Derivatives Use in the Treatment of Acute and Chronic Pain. Pain Physician, 2(20;2), sE23–sE31. https://doi.org/10.36076/ppj.2017.se31

Wang, Y., Sun, J., Tao, Y., Chi, Z., & Liu, J. (2010). The role of κ-opioid receptor activation in mediating antinociception and addiction. Acta Pharmacologica Sinica, 31(9), 1065–1070. https://doi.org/10.1038/aps.2010.138

Published

11-30-2024

How to Cite

Menon, S. (2024). Opioids and their Receptors. Journal of Student Research, 13(4). https://doi.org/10.47611/jsrhs.v13i4.7646

Issue

Section

HS Research Projects